Perez-Chada, Lourdes M.
Haberman, Rebecca H. http://orcid.org/0000-0002-7119-8136
Chandran, Vinod
Rosen, Cheryl F.
Ritchlin, Christopher
Eder, Lihi
Mease, Philip http://orcid.org/0000-0002-6620-0457
Reddy, Soumya
Ogdie, Alexis
Merola, Joseph F.
Scher, Jose U.
Article History
Accepted: 20 January 2021
First Online: 15 February 2021
Competing interests
: R.H.H. declares they have received consultation honoraria from Janssen. V.C. declares they have received research grants and/or advisory board honoraria from AbbVie, Amgen, BMS, Celgene, Eli Lilly, Janssen, Novartis, Pfizer and UCB. V.C. also declares that their spouse is employed by Eli Lilly. C.F.R. declares they have received consultation and/or investigator honoraria from AbbVie, Eli Lilly and Novartis. L.E. declares they have received consultation honoraria and non-restricted research and educational grants from AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer and UCB. P.M. declares they have received research grants, consultation and/or speaker honoraria from AbbVie, Amgen, BMS, Boehringer Ingelheim, Celgene, Eli Lilly, Galapagos, Gilead, GlaxoSmithKline, Janssen, Novartis, Pfizer, Sun Pharma and UCB. S.R. declares they have received consultation honoraria from Amgen, Janssen, Novartis and Pfizer and have been involved in clinical trials with Amgen and Celgene. A.O. declares they have received consultation honoraria from AbbVie, Amgen, BMS, Celgene, Corrona, Eli Lilly, Janssen, Novartis and Pfizer and have received grant support from Amgen (to Forward/National Databank for Rheumatic Disease) and from Novartis and Pfizer (to the University of Pennsylvania). J.F.M. declares they have received consultation and/or investigator honoraria from AbbVie, Arena, Avotres, Biogen, Celgene, Dermavant, Eli Lilly, EMD Sorono, Janssen, Leo Pharma, Merck, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma and UCB. J.U.S. declares they have received consultation and/or investigator honoraria from AbbVie, Janssen, Novartis, Pfizer, Sanofi and UCB. All other authors declare no competing interests.